Patent · US Active

Antibodies recognizing tau

US10906964B2 · kind B2 · utility

6Cited by
5References
65Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2017
Grant dateFeb 2, 2021
Priority date—
Expiry dateMay 7, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.